Kate E. Rogers
Parkville, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Establishment of the barrens habitat forming urchin, Tripneustes australiae on rocky reefs will increase impacts on macroalgae in Southeast Australia.
Journal: Marine environmental research
Published: May 27, 2026
Dual β-lactam therapy against high-risk Pseudomonas aeruginosa isolates: a dynamic in-vitro infection model study integrating population genomics with quantitative systems pharmacology modelling and simulations.
Journal: The Lancet. Microbe
Published: March 20, 2025
Effects of different resistance mechanisms on bacterial response to meropenem, ciprofloxacin, and their combination described by next-generation mechanism-based modelling.
Journal: International journal of antimicrobial agents
Published: December 06, 2024
The effects of single and multiple resistance mechanisms on bacterial response to meropenem.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 01, 2024
Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
Journal: International journal of antimicrobial agents
Published: January 19, 2024
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance.
Journal: Antimicrobial agents and chemotherapy
Published: July 10, 2023
Ceftolozane/tazobactam plus tobramycin against free-floating and biofilm bacteria of hypermutable Pseudomonas aeruginosa epidemic strains: Resistance mechanisms and synergistic activity.
Journal: International journal of antimicrobial agents
Published: February 22, 2023
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling.
Journal: The Journal of antimicrobial chemotherapy
Published: January 17, 2022
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model.
Journal: Antibiotics (Basel, Switzerland)
Published: December 02, 2021
Evaluation of Meropenem-Ciprofloxacin Combination Dosage Regimens for the Pharmacokinetics of Critically Ill Patients With Augmented Renal Clearance.
Journal: Clinical pharmacology and therapeutics
Published: November 05, 2020
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients.
Journal: Antimicrobial agents and chemotherapy
Published: August 26, 2019
Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
Journal: Antimicrobial agents and chemotherapy
Published: June 04, 2018
Last Updated: 09/26/2026